Literature DB >> 2941279

Single and multiple dose pharmacokinetics of ciprofloxacin.

U Ullmann, W Giebel, A Dalhoff, P Koeppe.   

Abstract

Penetration of ciprofloxacin into nasal secretion was studied in 20 healty volunteers to whom 500 mg oral ciprofloxacin was administered twice daily for eight days. Nasal secretion and blood samples were collected following the 1st and 15th dose and samples assayed microbiologically. Absolute concentrations of ciprofloxacin in serum and nasal secretion as well as kinetic parameters indicate that repeated administration did not result in significantly increased serum or nasal secretions levels although there was a tendency towards slight drug accumulation. The rate of penetration of ciprofloxacin into nasal secretion was 73% following the first oral dose and 90% following the 15th oral dose.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2941279     DOI: 10.1007/bf02013985

Source DB:  PubMed          Journal:  Eur J Clin Microbiol        ISSN: 0722-2211            Impact factor:   3.267


  15 in total

1.  Intraprostatic concentrations of ciprofloxacin after intravenous administration.

Authors:  J B Boerema; F M Debruyne; A Dalhoff
Journal:  Lancet       Date:  1984-09-22       Impact factor: 79.321

2.  Changes in the pharmacokinetics of ciprofloxacin and fecal flora during administration of a 7-day course to human volunteers.

Authors:  W Brumfitt; I Franklin; D Grady; J M Hamilton-Miller; A Iliffe
Journal:  Antimicrob Agents Chemother       Date:  1984-11       Impact factor: 5.191

3.  Pharmacokinetics of intravenously administered ciprofloxacin.

Authors:  R Wise; R M Lockley; M Webberly; J Dent
Journal:  Antimicrob Agents Chemother       Date:  1984-08       Impact factor: 5.191

4.  Dose- and sex-independent disposition of ciprofloxacin.

Authors:  D Höffler; A Dalhoff; W Gau; D Beermann; A Michl
Journal:  Eur J Clin Microbiol       Date:  1984-08       Impact factor: 3.267

5.  Multiple-dose ciprofloxacin kinetics in normal subjects.

Authors:  G E Aronoff; C H Kenner; R S Sloan; S T Pottratz
Journal:  Clin Pharmacol Ther       Date:  1984-09       Impact factor: 6.875

6.  [Quantitative determination of protein, albumin, and antibiotics in nasal secretions of healthy probands (author's transl)].

Authors:  W Giebel; K H Schönleber; H Breuninger; U Ullmann
Journal:  Arch Otorhinolaryngol       Date:  1979

7.  Pharmacokinetics of ciprofloxacin after oral and intravenous administration in healthy volunteers.

Authors:  W Wingender; K H Graefe; W Gau; D Förster; D Beermann; P Schacht
Journal:  Eur J Clin Microbiol       Date:  1984-08       Impact factor: 3.267

8.  Effect of standard breakfast on drug absorption and multiple-dose pharmacokinetics of ciprofloxacin.

Authors:  B Ledergerber; J D Bettex; B Joos; M Flepp; R Lüthy
Journal:  Antimicrob Agents Chemother       Date:  1985-03       Impact factor: 5.191

9.  Ciprofloxacin distribution in prostatic tissue and fluid following oral administration.

Authors:  J B Boerema; A Dalhoff; F M Debruyne
Journal:  Chemotherapy       Date:  1985       Impact factor: 2.544

10.  Ciprofloxacin concentrations in tonsils following a single intravenous infusion.

Authors:  N Falser; A Dalhoff; H Weuta
Journal:  Infection       Date:  1984 Sep-Oct       Impact factor: 3.553

View more
  10 in total

1.  Penetration of ciprofloxacin into human lung tissue following intravenous injection.

Authors:  D Schlenkhoff; A Dalhoff; J Knopf; W Opferkuch
Journal:  Infection       Date:  1986 Nov-Dec       Impact factor: 3.553

Review 2.  Ofloxacin clinical pharmacokinetics.

Authors:  K C Lamp; E M Bailey; M J Rybak
Journal:  Clin Pharmacokinet       Date:  1992-01       Impact factor: 6.447

Review 3.  The use of fluoroquinolones in chronic otitis suppurativa.

Authors:  P H van de Heyning; S R Pattyn; H D Valcke; D L van Caekenberghe; J Claes
Journal:  Pharm Weekbl Sci       Date:  1987-12-11

4.  Ciprofloxacin concentrations in tonsils following single or multiple administrations.

Authors:  N Falser; A Dalhoff; H Weuta
Journal:  Infection       Date:  1988       Impact factor: 3.553

5.  Cefpodoxime proxetil in patients with endstage renal failure on hemodialysis.

Authors:  D Höffler; P Koeppe; M Corcilius; A Przyklinik
Journal:  Infection       Date:  1990 May-Jun       Impact factor: 3.553

Review 6.  Pharmacokinetics of ciprofloxacin.

Authors:  T Bergan; A Dalhoff; R Rohwedder
Journal:  Infection       Date:  1988       Impact factor: 3.553

Review 7.  Clinical pharmacokinetics of the newer antibacterial 4-quinolones.

Authors:  M Neuman
Journal:  Clin Pharmacokinet       Date:  1988-02       Impact factor: 6.447

Review 8.  Ciprofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  D M Campoli-Richards; J P Monk; A Price; P Benfield; P A Todd; A Ward
Journal:  Drugs       Date:  1988-04       Impact factor: 9.546

9.  Comparative pharmacokinetics of new quinolones.

Authors:  H Lode; G Höffken; C Prinzing; P Glatzel; R Wiley; P Olschewski; B Sievers; D Reimnitz; K Borner; P Koeppe
Journal:  Drugs       Date:  1987       Impact factor: 9.546

Review 10.  Pharmacokinetic disposition of quinolones in human body fluids and tissues.

Authors:  F Sörgel; U Jaehde; K Naber; U Stephan
Journal:  Clin Pharmacokinet       Date:  1989       Impact factor: 6.447

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.